First-of-its-Kind clinic opens to track silent blood condition linked to cancer and heart disease
NCT ID NCT07313059
Summary
This study aims to understand the long-term health of people with clonal hematopoiesis (CH), a common blood condition in older adults that increases the risk of blood cancers and heart disease. Researchers will monitor 100 participants over time in Australia's first dedicated CH clinic, tracking their health, providing support, and building a database to guide future care. The goal is to learn how to best manage this condition, which is often found by chance but currently has no specific treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLONAL HEMATOPOIESIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Canberra Health Services
RECRUITINGCanberra, Australian Capital Territory, 2605, Australia
Contact
Conditions
Explore the condition pages connected to this study.